SurModics to Webcast Second Quarter 2016 Earnings Conference Call on May 2
April 28 2016 - 7:05PM
Business Wire
Webcast is Live at 4 p.m. (CT)
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that it will host a live webcast of its
second quarter fiscal 2016 conference call on Monday, May 2, at 4
p.m. CT (5 p.m. ET). The Company will issue an earnings news
release after the market closes that afternoon.
Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and chief financial officer,
will recap the second quarter 2016 financial results and
accomplishments. To access the webcast, go to the investor
relations portion of the Company’s website at www.surmodics.com the
day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7 p.m. CT on
Monday, May 2, until 7 p.m. CT on Monday, May 9, by
registering for the replay at
https://jsp.premiereglobal.com/webrsvp using replay passcode
8501461. In addition, the conference call audio and transcript will
be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics is known as the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD) tests
and microarrays. Following two recent acquisitions of Creagh
Medical and NorMedix, the company is executing on a key growth
strategy for its medical device business by expanding to offer
total intravascular product solutions to its medical device
customers. The combination of proprietary surface technologies,
along with enhanced device design, development and manufacturing
capabilities, enables SurModics to significantly increase the value
it offers with highly differentiated intravascular solutions
designed and engineered to the most demanding requirements. With
this focus on offering total solutions, SurModics’ mission remains:
to improve the detection and treatment of disease by using our
technology to provide solutions to difficult medical device and
diagnostic challenges. SurModics is headquartered in Eden Prairie,
Minnesota. For more information about the company, visit
www.surmodics.com. The content of SurModics’ website is not part of
this press release or part of any filings that the company makes
with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160428007056/en/
SurModics, Inc.Andy LaFrence, 952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024